Higher risk of cognitive impairment in Parkinson’s disease with comorbid diabetes
Objective: To determine the risk of cognitive impairment in individuals with Parkinson’s disease (PD) and diabetes. Background: Diabetes is associated with risk of cognitive impairment…Early cognitive impairment phenotype and functional connectivity in non-demented Parkinson’s disease patients
Objective: This study was designed to clarify the relationship between early cognitive decline and functional connectivity changes in non-demented Parkinson's disease (PD) patients. Background: Cognitive…Cardiovascular autonomic dysfunction, depression and cognitive disorders in Parkinson’s disease patients
Objective: The aim of the study was to determine the relationship between depression, cognitive disorders and autonomic regulation of the cardiovascular system in patients with…Neuropsychological predictors of patient-reported cognitive outcomes following deep brain stimulation
Objective: To identify preoperative cognitive performance measures associated with patient- and/or caregiver-reported cognitive decline following deep brain stimulation (DBS) surgery for movement disorders. Background: Patients…Parkinson Syndrome associated with inositol-1,4,5-triphosphate receptor antigen type 1 (ITPR1) antibodies
Objective: To illustrate an unusual clinical presentation of Parkinson´s disease (PD) that was effectively treated with immune adsorption. Background: Autoimmune mediated movement disorders may be…The efficacy of continuous apomorphine infusion in advanced PD patients with cognitive impairments
Objective: To review the outcome of continuous apomorphine infusion (CAI) in advanced Parkinson’s disease (PD) patients at the rehabilitation unit of the Parkinson Expertise Center…The value of classical cerebrospinal fluid protein ratios and peripheral inflammation in Parkinson’s disease cognitive impairment
Objective: To evaluate cerebrospinal fluid (CSF) levels of proteins associated with neuropathological inclusions and their ratios, and CSF and plasma levels of inflammatory proteins as…Cerebrospinal fluid lysosomal enzymes and cognition in Parkinson’s disease
Objective: To evaluate cerebrospinal fluid (CSF) levels of lysosomal enzymes and assess their relationship with cognition in PD as potential early biomarkers of cognitive failure.…Depression and Cognitive Performance in Patients with Parkinson’s Disease
Objective: The aim of this study was to assess the relationship between depression on cognitive performance in Parkinson’s disease patients. Background: There are very few…Subcortical local shape volume analysis of progressive mild cognitive impairment in Parkinson`s disease
Objective: We evaluated the role of subcortical structures in ongoing dementia in Parkinson’s disease (PD). Background: Cortical neural correlates of ongoing cognitive decline in PD…
- « Previous Page
- 1
- …
- 94
- 95
- 96
- 97
- 98
- …
- 117
- Next Page »